Veterinary Medicines

Bovilis Bovipast RSP suspension for injection for cattle

Authorised
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
Download as PDF

Product identification

Medicine name:
Bovilis Bovipast RSP suspension for injection for cattle
Bovilis Bovipast vet. Injektionsvätska, suspension
Active substance:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
    281838.00
    unit(s)
    /
    5.00
    millilitre(s)
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
    70794.60
    unit(s)
    /
    5.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
    100000.00
    unit(s)
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 18894
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0537/001
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • Greece
  • Italy
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 25/09/2024
Download
Swedish (PDF)
Published on: 23/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 23/01/2025
Download

Combined File of all Documents

English (PDF)
Published on: 25/09/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 23/01/2025
Download